论文部分内容阅读
目的研究分析硝苯地平缓释片联合酒石酸美托洛尔片治疗高血压的临床疗效。方法选取本院2015年12月至2016年12月收治的高血压患者60例,随机分为观察组和对照组各30例。观察组患者给予硝苯地平缓释片联合酒石酸美托洛尔片治疗,对照组患者给予硝苯地平片治疗,观察对比2组患者服药后的降压效果及出现不良反应的情况。结果服药后,观察组患者的降压效果和不良反应发生率明显优于对照组,其差异(χ2分别=10.417和14.067,P<0.05)。结论硝苯地平缓释片联合酒石酸美托洛尔片治疗高血压更加安全有效,控制了患者的高血压病情,减少了患者的生活不适,提高了患者的服药满意度。
Objective To study the clinical efficacy of nifedipine sustained-release tablets combined with metoprolol tartrate tablets in the treatment of hypertension. Methods Sixty hypertensive patients admitted from December 2015 to December 2016 in our hospital were randomly divided into observation group and control group with 30 cases each. Patients in the observation group were treated with nifedipine sustained-release tablets combined with metoprolol tartrate tablets, while patients in the control group were treated with nifedipine tablets. The antihypertensive efficacy and adverse reactions of the two groups were compared. Results After treatment, the antihypertensive effect and adverse reaction rate in the observation group were significantly better than those in the control group (χ2 = 10.417 and 14.067, P <0.05, respectively). Conclusion Nifedipine sustained-release tablets combined with metoprolol tartrate tablets in the treatment of hypertension is safer and more effective, which can control the patients’ hypertension, reduce the patients’ life discomfort and improve the patients’ medication satisfaction.